News In Theranostics

news article

Targeting Glioblastoma with Precision: The Promise of Lutetium-177 ITM-31

Thu Jul 10 2025

news article

SNMMI 2025: STARLiT: Stereotactic Body Radiotherapy and 177Lu PSMA-617 in Locally Advanced Prostate Cancer

Thu Jul 24 2025

news article

Improving Access to Nuclear Medicine: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD

Mon Jun 30 2025

news article

Groundbreaking Cancer Therapy Clinical Trial with U.S. Department of Energy’s Accelerator-Produced Actinium-225 Set to Begin this Summer

Wed Jun 18 2025

news article

Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals

Mon Jun 30 2025

news article

Ratio Therapeutics secures isotope supply deal with Nusano for radiopharmaceutical development

Mon Jun 23 2025

news article

PharmaLogic Completes Acquisition of Majority Stake in Agilera Pharma AS

Mon Jun 23 2025

news article

ITM and Debiopharm Announce First Patient Imaged in New Study Arm of Phase 1/2 Trial Evaluating ITM-94 as Diagnostic Agent for Clear Cell Renal Cell Carcinoma (ccRCC)

Mon Jun 23 2025

news article

SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging

Fri Jun 13 2025

news article

SNMMI: PET imaging improves OMD detection in breast cancer patients

Mon Jun 23 2025

news article

SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals

Wed Jun 25 2025

news article

PanTera produces and supplies first Actinium-225 extracted from Thorium-229 in Belgium.

Thu Jun 12 2025

news article

CLARITY PHARMACEUTICALS EXPANDS MANUFACTURING

Tue Jun 17 2025

news article

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

Wed Jun 25 2025

news article

Nusano Stable Isotope Program Enriches Gadolinium-160 to 99.2% Purity

Tue Jun 10 2025

news article

Telix’s Illuccix® PSMA-PET Imaging Agent Approved in Germany

Thu Jun 05 2025

news article

Rhenium Obisbemeda Improves Survival in Recurrent Glioblastoma

Fri May 30 2025

news article

Radiopharm’s HEAT Is On: First Patient Dosed in Pioneering HER2 Trial

Tue Jun 03 2025

news article

Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer

Mon Jun 02 2025

news article

Perspective Therapeutics Highlights Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the 2025 ASCO Annual Meeting

Fri May 30 2025

news article

[68Ga]Ga-PSMA-11 PET/CT and [18F]Fluorocholine PET/CT in Assessment and Clinical Decision Making of Recurrent Prostate Cancer: A Prospective Crossover Trial

Wed May 28 2025

news article

New Combination Therapy Safe and Feasible for Neuroendocrine Tumor Patients

Wed May 21 2025

news article

Blue Earth Therapeutics initiates Phase 2 Clinical Trial evaluating the efficacy and safety of Lutetium (177Lu) rhPSMA-10.1 Injection in metastatic castrate resistant prostate cancer

Thu May 01 2025

news article

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Mon May 19 2025

news article

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC)

Mon May 12 2025

news article

Ratio Therapeutics to construct radiopharmaceutical facility

Thu May 08 2025

news article

Novel Radiolabeled Antibody Developed for Diagnosis and Treatment of Solid Tumors

Thu Apr 17 2025

news article

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma

Fri Apr 25 2025

news article

SPECT/CT predicts overall survival in Pluvicto patients

Fri Apr 25 2025

news article

Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis

Mon Apr 28 2025

news article

Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano

Thu Apr 17 2025

news article

Novel Radiolabeled Antibody Developed for Diagnosis and Treatment of Solid Tumors

Thu Apr 17 2025

news article

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

Wed Apr 16 2025

news article

SECuRE trial update: First patient treated in the Phase II Cohort Expansion

Tue Apr 15 2025

news article

AdvanCell proudly announces $18M in Federal Funding from the Medical Research Future Fund (MRFF) Frontiers Initiative for ‘Defeating Prostate Cancer with Targeted Alpha Therapy’

Fri Apr 11 2025

news article

Curium enhances its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis

Thu Apr 10 2025

news article

PharmaLogic to Acquire Majority Stake in Agilera, Strengthening Global Expertise in Radiopharmaceutical Therapeutics

Wed Apr 09 2025

news article

Akiram Therapeutics initiates Eurostars-funded collaboration to develop next-generation targeted alpha-therapeutics

Fri Apr 04 2025

news article

FDA Approves Expanded Label of Novartis’ Prostate Cancer Treatment, Pluvicto

Fri Mar 28 2025

news article

Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma

Mon Mar 17 2025

news article

Telix Adds Lead-212 Isotope Production Capability

Thu Mar 13 2025

news article

Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer

Tue Mar 11 2025

news article

177-Lutetium-PSMA vs Cabazitaxel: A Real-World mCRPC Study - Mike Wenzel

Mon Mar 03 2025

news article

FES-PET shows promise staging patients with low-grade breast cancer

Tue Mar 04 2025

news article

Eckert & Ziegler Enters Strategic Partnership with Bicycle Therapeutics

Thu Feb 27 2025

news article

Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases

Wed Feb 26 2025

news article

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

Wed Feb 26 2025

news article

ASCO GU 2025: Seeing Is Believing: Radiographic Criteria to Assess Response

Thu Feb 13 2025

news article

New PET tracer developed for breast cancer

Fri Feb 14 2025

news article

Radiopharmaceutical Industry Trends Shaping 2025

Thu Feb 20 2025

news article

JNM Publishes Procedure Standard/Practice Guideline for Fibroblast Activation Protein PET

Fri Jan 24 2025

news article

Dosimetry key in Lu-177 cancer therapy

Wed Feb 05 2025

news article

Longtime manufacturer ITM's lead radiotherapy outperforms standard of care in phase 3 neuroendocrine tumor trial

Tue Jan 28 2025

news article

Nusano and Atley Solutions in Collaboration to Accelerate Astatine-211 Development

Thu Jan 16 2025

news article

Clarity to present COBRA and CLARIFY abstracts at two world-leading conferences

Tue Jan 28 2025

XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468